PHIO: the cash flow

MyFinsight

For the year ending 2025-12-31, PHIO had $15,649K increase in cash & cash equivalents over the period. -$7,991K in free cash flow.

Cash Flow	2025-12-31
Research and development	4,618
General and administrative	4,602
Total operating expenses	9,220
Other income, net	522
Net loss	-8,698
Depreciation and amortization	3
Amortization of right of use asset	0
Net gain/(loss) on disposal of property and equipment	0
Stock-based compensation	481
Prepaid expenses and other assets	91
Accounts payable	183
Accrued expenses	143
Lease liability	0
Net cash (used in) operating activities	-7,979
Cash paid for purchase of property and equipment	12
Asset sale proceeds	0
Net cash (used in) provided by investing activities	-12
Net proceeds from the exercise of warrants	5,755
Net proceeds from the issuance of common stock and warrants	17,915
Cash-in-lieu of fractional shares from reverse stock split	0
Payments to repurchase shares withheld for payroll taxes from restricted stock issuance	30
Net cash provided by financing activities	23,640
Net increase (decrease) in cash, cash equivalents and restricted cash	15,649
Cash and cash equivalents at the beginning of period	5,382
Cash and cash equivalents at end of period	21,031

Unit: Thousand (K) dollars (except for numbers of shares and EPS).